Dr. Aseem Malhotra

And of course, it doesn't take a rocket scientist to figure out if a doctor is making clinical decisions on corrupted and biased information making. At best, it's going to lead to suboptimal outcomes for patients, and at worst, it's going to do harm. And even pre-pandemic, the third most common cause of death, and this is still, when I talk about this at lectures, people gasp, even doctors.

And of course, it doesn't take a rocket scientist to figure out if a doctor is making clinical decisions on corrupted and biased information making. At best, it's going to lead to suboptimal outcomes for patients, and at worst, it's going to do harm. And even pre-pandemic, the third most common cause of death, and this is still, when I talk about this at lectures, people gasp, even doctors.

And of course, it doesn't take a rocket scientist to figure out if a doctor is making clinical decisions on corrupted and biased information making. At best, it's going to lead to suboptimal outcomes for patients, and at worst, it's going to do harm. And even pre-pandemic, the third most common cause of death, and this is still, when I talk about this at lectures, people gasp, even doctors.

The third most common cause of death globally after heart disease and cancer is prescribed medications, according to one, you know, analysis. So it's really a massive problem. It's a major public health issue. And what the main focus, and of course, you know, part of this Maha movement and what Robert Kennedy Jr.

The third most common cause of death globally after heart disease and cancer is prescribed medications, according to one, you know, analysis. So it's really a massive problem. It's a major public health issue. And what the main focus, and of course, you know, part of this Maha movement and what Robert Kennedy Jr.

The third most common cause of death globally after heart disease and cancer is prescribed medications, according to one, you know, analysis. So it's really a massive problem. It's a major public health issue. And what the main focus, and of course, you know, part of this Maha movement and what Robert Kennedy Jr.

and like, so Jay Bhattacharya and Marty Makary want to do is one of the most important things is to get the American population, you know, reducing the medications they're taking and then trying to empower them and create environments so they can flourish from a health perspective through lifestyle.

and like, so Jay Bhattacharya and Marty Makary want to do is one of the most important things is to get the American population, you know, reducing the medications they're taking and then trying to empower them and create environments so they can flourish from a health perspective through lifestyle.

and like, so Jay Bhattacharya and Marty Makary want to do is one of the most important things is to get the American population, you know, reducing the medications they're taking and then trying to empower them and create environments so they can flourish from a health perspective through lifestyle.

What I would say first and foremost is that when it comes to medical journal articles, you know, remember, there's industry sponsored trials. So if it comes from the drug industry, just don't believe any of it. And that is my view. That's the view of Catherine De Angelis, one of the earliest editors of JAMA.

What I would say first and foremost is that when it comes to medical journal articles, you know, remember, there's industry sponsored trials. So if it comes from the drug industry, just don't believe any of it. And that is my view. That's the view of Catherine De Angelis, one of the earliest editors of JAMA.

What I would say first and foremost is that when it comes to medical journal articles, you know, remember, there's industry sponsored trials. So if it comes from the drug industry, just don't believe any of it. And that is my view. That's the view of Catherine De Angelis, one of the earliest editors of JAMA.

With Ozempic, one of the issues with Ozempic is it basically stops you, it controls, you know, it reduces appetite massively. But the issue with the Zempik, which is a great concern, is that when you lose weight, you want to lose body fat. You don't lose muscle. And you basically end up losing 50% muscle, 50% body fat.

With Ozempic, one of the issues with Ozempic is it basically stops you, it controls, you know, it reduces appetite massively. But the issue with the Zempik, which is a great concern, is that when you lose weight, you want to lose body fat. You don't lose muscle. And you basically end up losing 50% muscle, 50% body fat.

With Ozempic, one of the issues with Ozempic is it basically stops you, it controls, you know, it reduces appetite massively. But the issue with the Zempik, which is a great concern, is that when you lose weight, you want to lose body fat. You don't lose muscle. And you basically end up losing 50% muscle, 50% body fat.

There are all these other side effects that, again, are underreported in the trials that we're now seeing in the real world, including stomach paralysis, nausea, vomiting. I think it probably has a role, Megan, in a very, very small minority of people who have tried everything and are morbidly obese and are really struggling. But I think 99% of people who are taking Ozempic shouldn't be on it.

There are all these other side effects that, again, are underreported in the trials that we're now seeing in the real world, including stomach paralysis, nausea, vomiting. I think it probably has a role, Megan, in a very, very small minority of people who have tried everything and are morbidly obese and are really struggling. But I think 99% of people who are taking Ozempic shouldn't be on it.

There are all these other side effects that, again, are underreported in the trials that we're now seeing in the real world, including stomach paralysis, nausea, vomiting. I think it probably has a role, Megan, in a very, very small minority of people who have tried everything and are morbidly obese and are really struggling. But I think 99% of people who are taking Ozempic shouldn't be on it.

I think it's going to do more harm than good. I think it has to be through a lifestyle change.

I think it's going to do more harm than good. I think it has to be through a lifestyle change.